Search details
1.
Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy.
Cancer Immunol Res
; 11(10): 1314-1331, 2023 10 04.
Article
in English
| MEDLINE | ID: mdl-37540803
2.
Imaging CAR T-cell kinetics in solid tumors: Translational implications.
Mol Ther Oncolytics
; 22: 355-367, 2021 Sep 24.
Article
in English
| MEDLINE | ID: mdl-34553024
3.
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.
J Clin Invest
; 130(11): 6109-6123, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-33074246
4.
CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy.
Oncoimmunology
; 6(2): e1273302, 2017.
Article
in English
| MEDLINE | ID: mdl-28344886
5.
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors.
Cancer Discov
; 6(2): 133-46, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26503962
6.
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
J Clin Invest
; 126(8): 3130-44, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27454297
7.
Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL.
PLoS One
; 8(8): e73375, 2013.
Article
in English
| MEDLINE | ID: mdl-23991192
8.
Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.
PLoS One
; 8(1): e54000, 2013.
Article
in English
| MEDLINE | ID: mdl-23326557
Results
1 -
8
de 8
1
Next >
>>